Givaudan SA (OTCMKTS:GVDNY - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $97.02 and traded as low as $86.88. Givaudan shares last traded at $86.96, with a volume of 25,639 shares.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. Barclays downgraded shares of Givaudan from a "hold" rating to a "strong sell" rating in a report on Friday, November 15th. Citigroup downgraded shares of Givaudan from a "buy" rating to a "neutral" rating in a research note on Thursday, October 17th.
View Our Latest Stock Report on Givaudan
Givaudan Stock Performance
The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.94 and a current ratio of 1.43. The business has a fifty day simple moving average of $91.90 and a two-hundred day simple moving average of $96.95.
About Givaudan
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Read More
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
